AI Scribe for Nurse Practitioners and Physician Assistants

A common gap in AI scribe coverage

Most AI scribe marketing is aimed at physicians. The marketing materials show physicians; the customer success teams default to physician workflow assumptions; the templates are optimized for MD/DO documentation patterns.

Nurse practitioners and physician assistants are a significant share of the primary care, urgent care, and many specialty workforces. Their documentation patterns differ from physician patterns in ways that affect whether AI scribes work well for them.

This article is about those differences. What works the same, what works differently, what scope-of-practice and supervisory considerations enter the picture, and what NPs and PAs should specifically test before adopting.

What works the same as physician practice

Most of what's been written about AI scribe adoption applies to NPs and PAs unchanged:

• The first-two-weeks slump curve is similar
• The consent conversation with patients is identical (the patient doesn't typically distinguish between an NP, PA, or MD for consent purposes)
• The audio setup considerations are the same
• The differential review pattern (skim safe sections, read risky ones) is identical
• The ROI math runs similarly per encounter

For a solo NP or PA with their own panel, the adoption playbook is essentially the same as for a solo physician. The articles on solo practice apply.

What works differently: scope and content

The documentation differences are subtle but matter:

The plan section often involves prescriber consultation. In many NP and PA practices (varies by state and provincial scope), prescribing of certain medications requires physician consultation, sign-off, or co-signature. The plan section of the note may include "discussed with Dr. X, will start [medication]" or similar consultation language. AI scribes don't always generate this language by default; the NP or PA needs to verify it's captured.

Some states have charting requirements specific to NPs. A few US states require additional documentation elements for NP encounters (e.g., supervising physician name in the chart, specific notation of independent vs. collaborative practice). The AI scribe needs to be configured to include these or the NP needs to add them in review.

Scope-defining language matters. "I diagnosed" vs. "I assessed" or "I treated" vs. "I administered per protocol" can have legal scope-of-practice implications depending on jurisdiction. The AI scribe's default phrasing may not match the practitioner's scope language. Customization addresses this; the customization step is more important for NPs and PAs in restrictive states than for physicians.

Standing orders and protocols. Many NP and PA practices operate under standing orders or clinical protocols. The note typically references this ("per clinic protocol, started X for Y"). AI scribes don't naturally include protocol references unless trained or customized to.

Supervising physician workflows

In US states with collaborative practice requirements for NPs or in PA practice (which always involves physician supervision in some form), the supervising physician relationship affects the documentation workflow.

The patterns:

Co-signature workflow. The NP or PA signs the note; the supervising physician co-signs within a specified window (often 24 to 72 hours). AI scribes need to support a co-signature workflow, which not all do by default. Verify with the vendor before signing up.

Pre-visit consultation. Some PAs are required to discuss complex cases with the supervising physician before the visit. This consultation may need to be documented separately. AI scribes typically don't capture this prep conversation; it stays in the PA's own notes.

Mid-visit consultation. When the NP or PA brings the supervising physician into the visit (sometimes physically, sometimes by phone), the AI scribe may or may not handle this transition well. Multi-speaker handling matters here; see AI scribe for group visits and multi-speaker encounters for the relevant constraints.

Post-visit review. Some practices have the supervising physician review certain types of NP/PA visits routinely. AI-generated notes that go through a review-and-edit cycle by the original clinician plus a co-signature by the supervisor have a more complex provenance trail. The audit logging should reflect this.

For NPs in full-practice states (where they can practice independently of physician supervision), these considerations are simpler; the workflow looks like physician workflow. For NPs in restricted or reduced-practice states, the considerations are more significant.

Prescribing documentation

Prescribing patterns differ between NPs/PAs and physicians, mostly because of scope and DEA scheduling considerations.

Controlled substance prescribing. PAs and NPs typically can prescribe controlled substances but with some state-by-state variation, and some practices have additional internal documentation requirements for these prescriptions. AI scribes should capture controlled substance prescribing accurately; misheard schedules (II vs III vs IV) can have meaningful regulatory implications. The medication accuracy considerations from what to do when your AI scribe mishears a medication apply with extra weight.

Buprenorphine prescribing. NPs and PAs with DEA waivers (or post-MAT Act with appropriate training) prescribe buprenorphine. The documentation for buprenorphine visits has specific requirements; AI scribes may or may not be tuned for them. Verify before relying.

Quantities and refills. NPs and PAs in some states have prescribing limits (quantity, refills, or duration). The note should reflect compliance with these limits. AI scribes don't enforce limits; they document what was prescribed. The clinician's review is where compliance with state-specific limits is verified.

E/M coding and billing implications

Many NPs and PAs bill under their own provider number; some bill under the supervising physician's number ("incident-to" in Medicare US). The billing structure affects what needs to be documented.

For independently billed NP/PA encounters, the documentation requirements for E/M codes are the same as for physician encounters. AI scribe quality affects code-defensibility the same way.

For incident-to billing, the supervising physician's involvement needs to be documented in addition to the encounter content. AI scribes typically don't capture this; it needs to be added in review.

The specific Medicare incident-to rules in 2026 require:

• The supervising physician must be in the office suite (not necessarily in the room)
• The supervising physician must have seen the patient for the initial visit
• The NP or PA is following an established plan of care

Documentation should reflect these conditions when incident-to billing is used. This is documentation the AI doesn't generate; it's added by the NP/PA or supervisor based on the actual billing pattern.

Time-based codes and supervision

Time-based codes (in primary care, codes like 99417 for prolonged services; in psychiatry, the time-based psychotherapy codes) require documentation of the time spent. Most AI scribes capture visit duration accurately but don't always surface it prominently in the note.

For NPs and PAs who use time-based codes routinely:

• Verify the AI scribe is capturing total face-to-face time, not just recording duration
• Verify the note distinguishes counseling/coordination time from total time (a coding distinction that matters)
• Add the time documentation manually if the AI's output doesn't include it

What NPs and PAs should test in a trial

The standard free trial evaluation applies, with these additions:

Test co-signature workflow if relevant. Have your supervising physician co-sign at least three AI-generated notes during the trial. Confirm the workflow is reasonable.

Test consultation documentation. If your practice involves physician consultation, run at least three visits where you document the consultation. Verify the AI captures it correctly or that you can add it efficiently.

Test prescribing documentation thoroughly. Prescribe a controlled substance during the trial (if you do this regularly). Verify the note captures the schedule, quantity, refills, and DEA number correctly. Misheard medications matter here more than usual.

Test billing documentation. If you use incident-to billing or time-based codes, verify the AI's notes support those billing patterns.

Have the supervising physician review at least 5 notes. Their input on whether the notes meet their standard for supervisory review is critical. If they have concerns, address them before committing.

Specialty considerations

Some NP and PA specialty patterns:

Urgent care. AI scribes work well in urgent care because the visits are usually two-speaker, focused, and have predictable structure. NPs and PAs in urgent care often see strong time savings.

Emergency medicine. PAs in EDs face more complex documentation: multi-speaker, often with multiple consults, high acuity, time pressure. AI scribes can help but the review burden is higher. Some practices use AI scribes for select visit types (low-acuity, single-complaint) and type higher-acuity visits.

Specialty clinics (cardiology, derm, ortho, etc.). AI scribes work similarly to how they work for physicians in these specialties. The same specialty-specific accuracy considerations apply.

Home health. PAs and NPs doing home health face the same multi-speaker and audio-environment challenges as physicians doing home health. The accuracy is lower than office visits but still useful for many practitioners.

Long-term care. SNF and assisted living rounds with shorter encounters per patient are a different rhythm. AI scribes may or may not save time; many providers find that the typing time per LTC encounter is already low, so the savings are smaller.

The collective opportunity

NPs and PAs collectively see a significant fraction of US and Canadian outpatient visits. The aggregate documentation burden is large. The AI scribe opportunity is correspondingly large, but the marketing-to-physician focus of most vendors means NPs and PAs sometimes encounter products that haven't been fully tested for their workflow.

The fix is straightforward: include NPs and PAs in the evaluation process, test their specific workflows, and pick vendors who treat NPs and PAs as first-class customers rather than as physician afterthoughts. Vendors that have built specifically for NP and PA practice are visible in their documentation, customer base, and customer success process; vendors that haven't are visible too, in the gaps.

---

For the broader workflow integration, see the first-week onboarding plan. For the team dynamics around adoption beyond the prescriber, getting your staff on board with AI scribes covers the rest of the clinical team's experience.